About Us | Contact Us | User Login

  • Home
  • About ForeseeHome
    • Learn More About ForeseeHome
    • Monitoring Process
    • Program Information
    • ForeseeHome FAQs
    • Technology
    • Published Research
    • Clinical Trials
      • AREDS2 ForeseeHome Study
      • Wet AMD Monitoring Study
  • Threat of AMD
    • Learn More About the Threat of AMD
    • Dry AMD
    • Wet AMD
    • Importance of Early Detection
    • Inherent Flaws of the Amsler Grid
    • AMD Resources
  • Patient Stories
  • In the News
  • Find a Doctor
    • First Prescriber Sites
    • AREDS2 Study Sites
    • Wet AMD Monitoring Study Sites
CSS Drop Down Menu by PureCSSMenu.com
  • Information for Physicians
    • ForeseeHome Program Information
    • ForeseeHome Physician FAQs
    • Publications
    • Case Studies
    • Physician Testimonials
    • For Current Practices
    • Events
    • Contact Us

TEXT

Home> In the News

In the News

ForeseeHome™ Featured on Washington D.C. Health News

 

Chevy Chase, MD (August 22, 2011) – Local news station WUSA9 recently featured the ForeseeHome AMD Monitoring Program in a health news alert.  Elizabeth Santee began using the ForeseeHome at the recommendation of her retina specialist, Dr. Richard Garfinkel at the Retina Group of Washington.  After about a month of using the device, she and her doctor received an alert. 

 

Dr. Garfinkel says, "It turns out she had a big problem, but it was too early for her to be able to detect it herself. The device detected it."

 

Elizabeth had three months of treatment and now doctors have her AMD under control.

 

"I am convinced that the early detection has saved my eye sight," Elizabeth tells us.

 

Click to watch story

 

 

About the ForeseeHome AMD Monitoring Program

The ForeseeHome AMD Monitor is a non-invasive, user friendly device designed specifically for use by patients with AMD.  Patients use their personal monitor daily in the comfort of their home, and results are transmitted automatically to the Notal Vision Data Monitoring Center through the phone line.  If a statistically significant change in vision is detected, Notal Vision will promptly alert the doctor and the patient so they can schedule a comprehensive eye exam.  Additionally, the doctor can view the patient’s data at any time through a secure website.

 

About Notal Vision
Notal Vision was founded in 2000 by ophthalmologists and medical professionals determined to reduce vision loss associated with Age-Related Macular Degeneration (AMD).  With leading experts in the field, this team of medical professionals and scientists developed a new technology for monitoring AMD, the leading cause of significant vision loss and blindness in the western world. This new technology, Preferential Hyperacuity Perimetry, is now providing eye care professionals around the world with valuable clinical data for monitoring patients with AMD.  The Notal Vision management team consists of medical and business professionals with offices in the U.S. and Israel.

 

More AMD News Click to read more news


Nortal Vision


 

 

© Copyright 2011 Notal VisionTM | Terms & Conditions | Privacy Policy | Customer Support Center: (888) 910-2020

Like us on Facebook Subscribe to our YouTube Channel